ReShape Lifesciences Surges to Top 231 in Trading Volume with $40.8 Million Turnover

On June 3, 2025, ReShape Lifesciences (RSLS) experienced a significant surge in trading volume, with a turnover of $40.8 million, marking a 137388.53% increase from the previous day. This substantial rise placed ReShape among the top 231 stocks by trading volume for the day. The stock price of ReShape Lifesciences (RSLS) rose by 56.61%.

Analysts at Alliance Global reduced their price target for ReShape Lifesciences from $4.65 to $1.75, reflecting a significant downward adjustment in their expectations for the company's stock performance.

ReShape Lifesciences has secured early EU/UK regulatory approval for its entire medical device portfolio, positioning the company among a select group of certified manufacturers. This regulatory milestone is expected to enhance the company's market standing and potentially drive future growth.